Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 61.57B | 61.01B | 59.53B | 56.50B | 53.17B | 52.71B |
Gross Profit | 19.89B | 19.73B | 19.04B | 17.98B | 16.73B | 15.99B |
EBITDA | 6.94B | 6.90B | 6.64B | 6.17B | 5.79B | 4.96B |
Net Income | 2.21B | 2.17B | 2.10B | 1.92B | 1.88B | 1.11B |
Balance Sheet | ||||||
Total Assets | 40.00B | 40.88B | 38.98B | 38.15B | 36.61B | 35.87B |
Cash, Cash Equivalents and Short-Term Investments | 1.94B | 2.11B | 1.95B | 1.93B | 2.44B | 1.94B |
Total Debt | 19.37B | 19.18B | 18.17B | 17.61B | 16.55B | 16.61B |
Total Liabilities | 28.89B | 29.61B | 27.36B | 26.69B | 24.88B | 24.75B |
Stockholders Equity | 10.96B | 11.09B | 11.46B | 11.30B | 11.57B | 10.99B |
Cash Flow | ||||||
Free Cash Flow | 3.75B | 3.60B | 3.58B | 3.18B | 3.65B | 4.03B |
Operating Cash Flow | 5.80B | 5.80B | 5.65B | 4.75B | 4.83B | 5.19B |
Investing Cash Flow | -2.37B | -2.02B | -1.84B | -2.37B | -1.27B | -1.38B |
Financing Cash Flow | -3.79B | -3.82B | -3.93B | -2.75B | -3.25B | -3.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | C$12.88B | 18.88 | 13.02% | 1.44% | 1.77% | 0.77% | |
78 Outperform | C$65.74B | 30.37 | 20.10% | 1.02% | 2.42% | 7.04% | |
78 Outperform | C$22.69B | 23.29 | 14.26% | 1.42% | 2.31% | 4.45% | |
76 Outperform | C$34.64B | 30.38 | 19.58% | 1.36% | 2.36% | -6.97% | |
70 Outperform | C$11.38B | 42.30 | -2.51% | 2.76% | 9.91% | -165.83% | |
65 Neutral | $26.77B | 15.22 | -4.18% | 3.21% | 1.01% | 1.53% | |
65 Neutral | C$2.30B | 16.68 | 18.85% | 3.33% | 4.19% | 2.56% |
Loblaw Companies Limited announced the election of its board of directors at the annual shareholders’ meeting. All nominated directors were elected, indicating strong shareholder support and stability in the company’s governance. This election is crucial for maintaining strategic direction and ensuring continued leadership in the Canadian retail market.
Loblaw Companies Limited reported a 4.1% revenue growth and a 9.3% increase in adjusted diluted net earnings per share for the first quarter of 2025. The company achieved strong sales momentum through customer response to value offerings and loyalty programs, with notable growth in both food and drug retail segments. Loblaw’s strategic expansion included opening new stores and clinics, contributing to its market share gains and financial performance.